Mesenchymal stem cells ameliorate postpyelonephritic renal scarring in rats

Area of Science:

• Regenerative Medicine
• Nephrology
• Stem Cell Biology

Background:

• Pyelonephritis, a bacterial kidney infection, can lead to significant renal scarring and long-term kidney damage.
• Current treatments for pyelonephritis focus on infection control, with limited options for mitigating subsequent renal scarring.
• Mesenchymal stem cells (MSCs) have demonstrated immunomodulatory and regenerative properties in various preclinical models.

Purpose of the Study:

• To investigate the efficacy of mesenchymal stem cells (MSCs) in ameliorating renal scarring following pyelonephritis in a rat model.
• To assess the migration and differentiation potential of MSCs within the renal tissue after treatment.
• To evaluate the impact of MSCs on both acute inflammation and chronic fibrotic changes in the kidney.

Main Methods:

• A rat model of pyelonephritis was established using Escherichia coli infection.
• Three groups were studied: sham-operated controls (with or without MSCs), pyelonephritis model, and pyelonephritis with MSCs treatment.
• Histopathological analysis was performed at acute (8 days) and chronic (6 weeks) time points to assess inflammation and scarring. MSCs' presence and differentiation (aquaporin-1 expression) were evaluated.

Main Results:

• MSCs-treated pyelonephritis rats (Group 3) exhibited significantly lower scores for both acute and chronic histopathological alterations compared to untreated pyelonephritis rats (Group 2).
• Mesenchymal stem cells were detected within the renal tubules of treated rats, expressing aquaporin-1, indicating differentiation into tubular cells.
• No MSCs were detected in the kidney tissue of sham-operated rats that received MSCs, suggesting targeted migration to injured tissue.

Conclusions:

• Mesenchymal stem cells effectively migrated to renal tissues in the pyelonephritis model.
• MSCs demonstrated a significant ameliorating effect on renal scarring, reducing both acute and chronic histopathological damage.
• The differentiation of MSCs into renal tubular cells suggests a potential mechanism for their renoprotective effects in pyelonephritis.